Devices › Catheter, hemodialysis, implanted
Device brand name · Blood access device
Lifesite Hemodialysis Access System: medical device reports filed with FDA
342 reports name it, 2001–2005. Manufacturer given most often on reports: Vasca. Product code MSD.
- 342
- device reports naming the brand
- 0% of all MAUDE reports · about 13 a year
- 0
- reports, 12 months to August 2026
- 0 in the 12 months before
- 9.1%
- classified as malfunction
- 75.8% across the product code
- 6.4%
- classified as death, as reported
- 22 reports · not verified by FDA
FDA's MAUDE database holds 342 reports that name the brand "Lifesite Hemodialysis Access System" (blood access device), received between January 2001 and December 2005; the manufacturer given most often on reports is Vasca. Spellings of one product vary from report to report.
0 reports arrived in the 12 months to August 2026, and none in the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are injury (82.5%), malfunction (9.1%) and death (6.4%); across all catheter, hemodialysis, implanted reports (product code MSD) death is recorded in 2.6% and malfunction in 75.8%. Event type is the reporter's classification of the report, not a verified outcome.
The device problems coded most often are explanted (60.2%), replace (17%) and device remains implanted (11.1%). The patient problems coded most often are surgical procedure, hospitalization required and treatment with medication(s). FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Reports by month, five years
No report naming Lifesite Hemodialysis Access System was received in the five years to August 2026; the latest was received in December 2005.
By year received
Event type and report source
Event type, as classified on the report
Who filed the report
Grey bar: all 11,458 reports carrying product code MSD. Event type is the filer's classification and is not verified by FDA.
Device problems coded
| Device problem (FDA code) | Reports | Share | Share across product code |
|---|---|---|---|
| Explanted | 206 | 60.2% | 7.6% |
| Replace | 58 | 17% | 3.4% |
| Device remains implanted | 38 | 11.1% | 0.8% |
| Leak/splashthe device leaked | 18 | 5.3% | 8.6% |
| Difficult to insertthe device was hard to insert | 12 | 3.5% | 1.2% |
| Other (for use when an appropriate device code cannot be identified) | 12 | 3.5% | 0.6% |
| Detachment of device component | 9 | 2.6% | 2.9% |
| Implant, removal of | 7 | 2% | 0.9% |
| Device issuea problem with the device | 5 | 1.5% | 0.2% |
| Defective devicethe device was defective | 4 | 1.2% | 0.3% |
| Restricted flow rate | 4 | 1.2% | 2.1% |
| Sticking | 4 | 1.2% | 0.4% |
| Bent | 3 | 0.9% | 0.2% |
| Device, removal of (non-implant) | 3 | 0.9% | 0.9% |
| Difficult to position | 3 | 0.9% | 0.1% |
| Kinkedthe tube or line kinked | 3 | 0.9% | 1.1% |
| Source, detachment from | 3 | 0.9% | 0.3% |
| Valve(s), defective | 3 | 0.9% | 0% |
| Valve(s), failure of | 3 | 0.9% | 0% |
| Valve(s), sticking | 3 | 0.9% | 0% |
FDA's device problem codes as entered on the report; one report can carry several. Generic codes such as "no apparent adverse event" are left out.
Patient problems coded
| Patient problem (FDA code) | Reports | Share |
|---|---|---|
| Surgical procedure | 152 | 44.4% |
| Hospitalization required | 78 | 22.8% |
| Treatment with medication(s) | 57 | 16.7% |
| Surgical procedure, repeated | 49 | 14.3% |
| Fever | 40 | 11.7% |
| Therapy/non-surgical treatment, additional | 39 | 11.4% |
| Bacterial infectiona bacterial infection | 34 | 9.9% |
| Surgical procedure, additional | 31 | 9.1% |
| Deaththe patient died; cause not stated by this term | 30 | 8.8% |
| Bleeding | 26 | 7.6% |
| Chillschills or shivering | 26 | 7.6% |
| Other (for use when an appropriate patient code cannot be identified) | 18 | 5.3% |
| Sepsisa severe body-wide response to infection | 16 | 4.7% |
| Staphylococcus aureus | 16 | 4.7% |
| Hematomaa collection of blood under the skin or in tissue | 11 | 3.2% |
Patient problem codes are present mainly in reports filed since 2019 and are often blank.
In context
| Measure | Lifesite Hemodialysis Access System | Product code MSD | All MAUDE reports |
|---|---|---|---|
| Reports | 342 | 11,458 | 26,136,888 |
| Share of that pool | — | 3% | 0% |
| Classified as death, per 1,000 reports | 64 | 26 | 9 |
| Classified as injury | 82.5% | 20% | 36.2% |
| Classified as malfunction | 9.1% | 75.8% | 62.3% |
| Filed by the manufacturer | 99.4% | 94.7% | 94.9% |
Shares are of reports, not of devices in use. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Other brands with product code MSD
| Brand | Reports | Latest 12 months | Classified as death |
|---|---|---|---|
| Palindrome | 1,473 | 52 | 1.3% |
| GlidePath | 775 | 225 | 0.9% |
| HemoStar | 361 | 84 | 0.8% |
| Equistream Split Tip | 296 | 125 | 0% |
| Arrow Hemodialysis Kit 2-L 15 Fr X 19 Cm | 267 | 40 | 0.4% |
| HemoSplit Catheter | 249 | 49 | 1.6% |
| Ash Split Catheter | 258 | 0 | 3.5% |
| Dialysis Unknown | 402 | 6 | 5% |
| Mahurkar | 1,046 | 6 | 1.1% |
| Angiodynamics / Bioflo | 163 | 0 | 0% |
| Vaxcel Pasv Picc | 286 | 0 | 0.7% |
| Bardia Foley Catheter Silicone Coated | 2,420 | 193 | 0% |
| AngioDynamics | 174 | 14 | 1.7% |
| Cadd Ms3 Pump | 719 | 0 | 0% |
| Fresenius Dialysis Delivery System | 364 | 0 | 11% |
Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA also states that "common products may have a higher number of adverse events due to the higher total number of people using the product."
Questions about Lifesite Hemodialysis Access System reports
How many FDA reports name Lifesite Hemodialysis Access System?
342 medical device reports in the openFDA MAUDE release of 28 Sep 2026, covering reports received through August 2026; 0 in the latest 12 months.
What kinds of events are reported?
injury (82.5%), malfunction (9.1%) and death (6.4%). "Event type" is how the report was classified when filed: death, injury, malfunction or other.
What device problems are coded?
explanted (60.2%), replace (17%), device remains implanted (11.1%), leak/splash (5.3%) and difficult to insert (3.5%). These are FDA's device problem codes as entered on the report.
Who files these reports?
manufacturer reports (99.4%) and voluntary reports (0.6%). Manufacturers and user facilities are required to report; voluntary reports come from health professionals and the public.
Do these reports show that Lifesite Hemodialysis Access System was at fault?
No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA adds that "a causal relationship cannot be established between product and reactions listed in a report."
How do I report a problem with a medical device?
Through FDA MedWatch (Form FDA 3500 for health professionals and consumers), or to the manufacturer. See the guide on how to report.
Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. A report counts here when any device it lists carries this brand name after punctuation and capitalisation are normalised. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.
Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.